RF Stock Analysis: Eurazeo | PA

Asset Management | PA, France | Market Cap: 2.849m EUR | 12M Return: -18% | FR0000121121 | Charts, Fundamentals & Technical Analysis

Private Equity, Venture Capital, Real Estate, Growth Capital
Total Rating 18
Safety 22
Buy Signal -0.25
Asset Management
Industry Rotation: -5.5
Market Cap: 3.21B
Avg Turnover: 3.18M
Risk 3d forecast
Volatility26.4%
VaR 5th Pctl4.73%
VaR vs Median8.80%
Reward TTM
Sharpe Ratio-0.77
Rel. Str. IBD45
Rel. Str. Peer Group59.7
Character TTM
Beta1.080
Beta Downside1.011
Hurst Exponent0.596
Drawdowns 3y
Max DD53.15%
CAGR/Max DD0.00
CAGR/Mean DD0.00

Warnings

Fakeout

Tailwinds

Confidence

Seasonality 11.7 years of data

Jan +5.3% 32
Feb -2.6% 23
Mar +1.4% 18
Apr +2.1% 20
May +0.5% 5
Jun -3.7% 34
Jul +1.9% 5
Aug -1.1% 19
Sep +2.2% 27
Oct -4.3% 16
Nov +0.1% 2
Dec +0.5% 14

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: RF Eurazeo

Eurazeo SE is a French-listed private equity and venture capital firm that invests across the capital structure, from growth capital and Series C rounds to leveraged buyouts and buy-ins, targeting upper mid-market, mid-market, and listed public companies. The firm has no strict sector restrictions but shows a clear preference for consumer brands (beauty, personal care, apparel, food, wellness), digital health, fintech, real estate, smart cities, mobility, luxury, and business services, with a thematic emphasis on digital transformation and shifting consumer lifestyles. Investments are concentrated in Western Europe-especially France and Italy-alongside the United States and China.

As a publicly traded asset manager with a mid-cap market capitalization of roughly $3.4 billion USD, Eurazeo generates revenue primarily through management fees and carried interest on its funds, the standard economic model for listed private equity firms. It seeks companies with differentiated concepts and global growth potential, deploying capital across both controlling buyout stakes and minority growth investments.

Headlines to Watch Out For
  • European rate hikes pressure real estate portfolio valuations
  • Portfolio exits and IPO realizations boost NAV
  • Private equity AUM growth drives fee income expansion
Piotroski VR-10 (Strict) 2.0
Net Income: -100.8m TTM > 0 and > 6% of Revenue
FCF/TA: -0.01 > 0.02 and ΔFCF/TA -1.52 > 1.0
NWC/Revenue: -84.65% < 20% (prev -1.17k%; Δ 1.09k% < -1%)
CFO/TA -0.01 > 3% & CFO -53.5m > Net Income -100.8m
Net Debt/EBITDA: error (EBITDA <= 0)
Current Ratio: 0.35 > 1.5 & < 3
Outstanding Shares: last quarter (63.9m) vs 12m ago -12.44% < -2%
Gross Margin: 53.29% > 18% (prev 1.37%; Δ 51.91% > 0.5%)
Asset Turnover: 8.64% > 50% (prev 1.20%; Δ 7.44% > 0%)
Interest Coverage Ratio: -1.35 > 6 (EBIT TTM -95.0m / Interest Expense TTM 70.5m)
Altman Z'' 4.95
A: -0.08 (Total Current Assets 336.6m - Total Current Liabilities 964.2m) / Total Assets 8.23b
B: 0.71 (Retained Earnings 5.89b / Total Assets 8.23b)
C: -0.01 (EBIT TTM -95.0m / Avg Total Assets 8.58b)
D: 3.04 (Book Value of Equity 6.01b / Total Liabilities 1.97b)
Altman-Z'' = 4.95 = AAA
Beneish M -0.36
DSRI: 0.15 (Receivables 246.1m/243.5m, Revenue 741.5m/107.1m)
GMI: 0.03 (GM 1.37% / 53.29%)
AQI: 1.01 (AQ_t 0.95 / AQ_t-1 0.94)
SGI: 6.92 (Revenue 741.5m / 107.1m)
TATA: -0.01 (NI -100.8m - CFO -53.5m) / TA 8.23b)
Beneish M = -0.36 (Cap -4..+1) = D
What is the price of RF shares?

As of October 07, 2026, the stock is trading at EUR 45.64 with a total of 62,458 shares traded. Over the past week, the price has changed by +0.18%, over one month by -6.28%, over three months by +8.77% and over the past year by -18.02%.

Current recommended Stop Loss: 44.20 (which is 3.2% or 1.4 ATR below the current price).

Is RF a buy, sell or hold?

Eurazeo has no consensus analysts rating.

Eurazeo (RF) - Fundamental Data Overview as of 03 October 2026
Market Cap USD = 3.21b (2.85b EUR * 1.12543 EUR.USD)
P/E Forward = 15.4321
P/S = 8.119
P/B = 0.5021
P/EG = 0.0293
Revenue TTM = 741.5m EUR
EBIT TTM = -95.0m EUR
EBITDA TTM = -70.2m EUR
Long Term Debt = 618.7m EUR (from longTermDebt, last quarter)
Short Term Debt = 964.2m EUR (from shortTermDebt, last quarter)
Debt = 1.72b EUR (from shortLongTermDebtTotal, last quarter) + Leases 76.2m
Net Debt = 1.64b EUR (calculated: Debt 1.72b - CCE 85.9m)
Enterprise Value = 4.49b EUR (2.85b + Debt 1.72b - CCE 85.9m)
Interest Coverage Ratio = -1.35 (Ebit TTM -95.0m / Interest Expense TTM 70.5m)
EV/FCF = -79.79x (Enterprise Value 4.49b / FCF TTM -56.2m)
FCF Yield = -1.25% (FCF TTM -56.2m / Enterprise Value 4.49b)
FCF Margin = -7.59% (FCF TTM -56.2m / Revenue TTM 741.5m)
Net Margin = -13.60% (Net Income TTM -100.8m / Revenue TTM 741.5m)
Gross Margin = 53.29% ((Revenue TTM 741.5m - Cost of Revenue TTM 346.4m) / Revenue TTM)
Gross Margin QoQ = -14.22% (prev 82.70%)
Tobins Q-Ratio = 0.54 (Enterprise Value 4.49b / Total Assets 8.23b)
Interest Expense / Debt = 4.09% (Interest Expense 70.5m / Debt 1.72b)
Taxrate = 25.0% (non-US conservative default 25%)
NOPAT = -71.3m (EBIT -95.0m * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 0.35 (Total Current Assets 336.6m / Total Current Liabilities 964.2m)
Debt / Equity = 0.29 (Debt 1.72b / totalStockholderEquity, last quarter 6.01b)
 Debt / EBITDA = -23.34 (negative EBITDA) (Net Debt 1.64b / EBITDA -70.2m)
 Debt / FCF = -29.14 (negative FCF - burning cash) (Net Debt 1.64b / FCF TTM -56.2m)
 Total Stockholder Equity = 6.54b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.17% (Net Income -100.8m / Total Assets 8.23b)
RoE = -1.54% (Net Income TTM -100.8m / Total Stockholder Equity 6.54b)
RoCE = -1.33% (EBIT -95.0m / Capital Employed (Equity 6.54b + L.T.Debt 618.7m))
 RoIC = -0.87% (negative operating profit) (NOPAT -71.3m / Invested Capital 8.20b)
 WACC = 7.25% (E(2.85b)/V(4.57b) * Re(9.78%) + D(1.72b)/V(4.57b) * Rd(4.09%) * (1-Tc(0.25)))
Discount Rate = 9.78% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -71.83 | Cagr: -7.81%
 [DCF] Fair Price = unknown (Cash Flow -56.2m)
 EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: -31.55 | Revenue CAGR: -29.22% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=2.23 | Chg30d=+4.36% | Revisions=+25% | GrowthEPS=+140.3% | GrowthRev=+0.4%
EPS next Year (2027-12-31): EPS=8.62 | Chg30d=+15.06% | Revisions=-25% | GrowthEPS=+285.8% | GrowthRev=+19.1%
[Analyst] Revisions Ratio: +0% (up=1, down=1)